Compounding The Problem: Congress, FDA Argue Over Regulatory Responsibility

The answer to FDA’s legal problems with regulating compounding may come through a designation of responsibility rather than a formal expansion of authority.

Commissioner Margaret Hamburg labored through hours of criticism from House and Senate committees during two days of hearings to defend FDA actions related to the problems at the New England...